Our solution reduces the risk of relapse as well as the costs incurred by healthcare systems.
Benefits for insurance companies
Benefits for insurance companies
“Reducing the risk of relapse to reduce the costs undertaken by health systems.”
Each year, 20 billion euros are spent by the state and the French health insurance system to prevent and manage the consequences of substance abuse.
During the period of abstinence, so-called “withdrawal” symptoms appear, increasing the risk of relapse for the addict. In addition, the associated treatments have many side effects (nausea, abnormal dreams, insomnia, headaches), causing many patients to stop treatment.
20 billion
spent each year by the state and the health insurance
The use of these substances leads to serious illnesses, the treatment of which is very expensive. The price of chemotherapy can reach several tens of thousands of euros. Among these diseases, there are many cancers: lung cancer, mostly due to tobacco, or cancers of the upper aerodigestive tract (mouth, pharynx, larynx) caused by excessive alcohol consumption.
Limiting the risk of relapse will be possible thanks to our therapeutic app
Our software, associated with Machine Learning, detects early the risk of relapse and proposes a “tailor-made” digital therapy according to the patient’s needs.
As a result, our software will reduce the cost of addiction care, thus reducing the number of relapses and comorbidities.
Benefits for insurance companies
“Reducing the risk of relapse to reduce the costs undertaken by health systems.”
Each year, 20 billion euros are spent by the state and the French health insurance system to prevent and manage the consequences of substance abuse.
During the period of abstinence, so-called “withdrawal” symptoms appear, increasing the risk of relapse for the addict. In addition, the associated treatments have many side effects (nausea, abnormal dreams, insomnia, headaches), causing many patients to stop treatment.
20 billion
spent each year by the state and the health insurance
The use of these substances leads to serious illnesses, the treatment of which is very expensive.
The price of chemotherapy can reach several tens of thousands of euros. Among these diseases, there are many cancers: lung cancer, mostly due to tobacco, or cancers of the upper aerodigestive tract (mouth, pharynx, larynx) caused by excessive alcohol consumption.
Limiting the risk of relapse will be possible thanks to our therapeutic app
Our software, associated with Machine Learning, detects early the risk of relapse and proposes a “tailor-made” digital therapy according to the patient’s needs.
As a result, our software will reduce the cost of addiction care, thus reducing the number of relapses and comorbidities.
